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DOI 10.1186/s12913-017-2476-9RESEARCH ARTICLE Open AccessFrom habits of attrition to modes of
inclusion: enhancing the role of private
practitioners in routine disease surveillance
Revati K. Phalkey1,2,3* , Carsten Butsch3, Kristine Belesova4, Marieke Kroll3 and Frauke Kraas3Abstract
Background: Private practitioners are the preferred first point of care in a majority of low and middle-income
countries and in this position, best placed for the surveillance of diseases. However their contribution to routine
surveillance data is marginal. This systematic review aims to explore evidence with regards to the role, contribution,
and involvement of private practitioners in routine disease data notification. We examined the factors that
determine the inclusion of, and the participation thereof of private practitioners in disease surveillance activities.
Methods: Literature search was conducted using the PubMed, Web of Knowledge, WHOLIS, and WHO-IRIS
databases to identify peer-reviewed and gray full-text documents in English with no limits for year of publication or
study design. Forty manuscripts were reviewed.
Results: The current participation of private practitioners in disease surveillance efforts is appalling. The main
barriers to their participation are inadequate knowledge leading to unsatisfactory attitudes and misperceptions that
influence their practices. Complicated reporting mechanisms with unclear guidelines, along with unsatisfactory
attitudes on behalf of the government and surveillance program managers also contribute to the underreporting of
cases. Infrastructural barriers especially the availability of computers and skilled human resources are critical to
improving private sector participation in routine disease surveillance.
Conclusion: The issues identified are similar to those for underreporting within the Integrated infectious Disease
Surveillance and Response systems (IDSR) which collects data mainly from public healthcare facilities. We
recommend that surveillance program officers should provide periodic training, supportive supervision and offer
regular feedback to the practitioners from both public as well as private sectors in order to improve case
notification. Governments need to take leadership and foster collaborative partnerships between the public and
private sectors and most importantly exercise regulatory authority where needed.
Keywords: Private-practitioners participation, Disease surveillance, Barriers and facilitatorsBackground
The 2016 outbreak of Zika virus across twenty countries
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posed the inability of the fragile public health systems
within the countries to respond swiftly or to preempt
the scale of the problem [2, 3].
Government spending on health is alarmingly low in a
majority of low and middle-income countries, which
leaves the public healthcare system chronically under-
funded and impoverished [4]. Often forcing them to make
compromises on the quality of care and fueling issues with
patient satisfaction and acceptance [5]. Furthermore rou-
tine surge functioning over years leaves them vulnerable
to breakdowns at the lowest level of imbalance. In thele is distributed under the terms of the Creative Commons Attribution 4.0
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within the public healthcare sector, the private sector has
gained strength globally [6]. Private health service provision
is significant and dominant particularly in urban areas
[7, 8]. Currently, more than half of the global population
lives in urban areas. This number is expected to rise to
66%9 as the population races to 9.7 billion by 2050 [9, 10].
We will probably witness a simultaneous and proportionate
surge in both the demand and supply of private healthcare
in both rural as well as urban areas globally.
Private practitioners are the preferred first point of
care in emerging economies because of perceived qual-
ity, lower costs, speedy care, flexibility of payments, and
accessibility [5, 11]. They already account for over 50–
80% of the out and in-patient care in countries like
India, China, South Africa, Brazil, and Nigeria amongst
others [7, 12, 13] In their position private primary care
practitioners are best placed for the early detection of
outbreaks as well as routine monitoring of disease
trends. However, their role in current disease control
programs is largely limited to service provision and out-
break response [14]. Their contribution to health infor-
mation systems is in most countries marginal and
largely voluntary, leading to gross misrepresentation and
underestimation of disease burdens [15, 16]. Therefore
involving the private sector in routine disease surveil-
lance is no longer a choice but a necessity.
While public-private partnerships can be cost-effective
[17] and have been widely and successfully implemented
in several individual disease control programs e.g. HIV/
tuberculosis, polio, malaria etc. [18], their potential for
routine disease surveillance remains largely untapped.
The objective of this systematic literature review is to
explore the experiences made across emerging econ-
omies with regard to the role, contribution, and involve-
ment of private practitioners in disease notification. We
examine the factors that determine the inclusion of and
the participation thereof of private practitioners in sur-
veillance activities.
Methods
A systematic literature search was conducted in Septem-
ber and October 2015 with an additional update in Feb-
ruary 2016 using the databases PubMed and Web of
Science. Grey literature searches were conducted using
WHOLIS (Library and Information Networks for Know-
ledge Database) WHO-IRIS (Institutional Repository for
Information Sharing) and the CDC Stacks databases.
The PRISMA Statement checklist for systematic reviews
was referred for the review process [19].
Inclusion criteria were set at peer-reviewed, and grey
full text empirical, original articles in English with no
limits for year of publication or study design. The key
search terms used in permutations and combinationsincluded “private practitioner” (“private practice”, “private
sector”, “private healthcare provider*”, “private facility*”,
“non-public sector”, “non-public physician”, “for profit sec-
tor”, “for profit facility” “private physician”) and “disease
surveillance” (“public health surveillance”, “sentinel surveil-
lance”, “population surveillance”, “epidemiological monitor-
ing”, “information systems”, “hospital information systems”,
“health information systems”, “management information
systems”, “ambulatory care information systems”, “auto-
matic data processing”, “electronic health records”). Search
algorithms always included terms related to private practice
and disease surveillance (Additional file 1). Search results
were merged using EndNote X7 and duplicates removed.
All articles (136) selected on the basis of title and ab-
stracts were retrieved. Manual screening of reference
lists identified eight further articles. A total of 144 arti-
cles were reviewed full text and data extracted by two
reviewers (CB and KB) and verified independently (RP).
Disagreements (13 articles) were resolved with mutual
consent. Studies that explicitly investigated the role of
private practitioners in routine disease surveillance were
conducted in low and middle-income countries as de-
fined by The World Bank [20] were included in the final
review. The main reasons for exclusion of 94 articles
(Fig. 1) included a lack of focus on routine disease sur-
veillance, studies from high-income countries followed
by non/full text opinion or review papers.
Limitations of the review
The searches were conducted in four databases and lim-
ited to English language only which may have led to a
degree of selection bias. We also used a narrow defin-
ition of private sector to include only practitioners ex-
cluding NGOs, laboratories, and pharmacies and the
informal sector (unregistered or untrained) stakeholders,
which limits the generalizability our findings to the pri-
vate sector. We limited our search to emerging econ-
omies. Important lessons could have been drawn from
experiences in the developed economies. About a third
of the studies were intervention studies, which could
have influenced the reporting behaviors of the practi-
tioners. Additionally the studies were conducted in very
different settings, at different scales for single and mul-
tiple diseases with both mandatory and voluntary report-
ing systems for different periods of observation as well
as differing study designs. The heterogeneity of the stud-
ies meant that we were unable to perform in-depth ana-
lyses of the factors and could not draw generalizable
inferences. For the purpose of the review we extracted
data on the lessons learned and factors reported to influ-
ence reporting as identified in these studies and aim to
present a summary of the facilitators and barriers to pri-
vate sector involvement in routine surveillance. There
were no major differences across the findings from these
Fig. 1 PRISMA flow diagram summarizing the literature search process
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discussions and identifying specific areas of in-depth re-
search in the future.Results
Overview of the studies
Forty studies were included in the review (Table 1). In
addition, we found ten review papers that provided detailed
recommendations. We present them as supporting studies
only (Table 2). The review summarizes the experiences
drawn in 28 countries. The studies span 13 countries in
Asia (Bangladesh, China, Iran, India, Indonesia, Malaysia,
Myanmar, Nepal, Pakistan, Philippines, Taiwan, Thailand,
and Vietnam), six in Africa (Ethiopia, Kenya, Morocco,
Nigeria, South Africa, and Uganda) and nine in the
South American region (Bolivia, Costa Rica, Dominican
Republic, El Salvador, Guatemala, Honduras, Mexico,
Nicaragua, and Peru).
All the studies except one [21] were single country
studies conducted between 1996 and 2015 and a major-
ity of them were from India (15, 37.5%) [14, 22–37]. The
scale of the studies varied from small city areas to the
national levels, but about half (19, 47.5%) of them wereconducted at an individual city level [11, 16, 17, 22, 23,
28, 31, 33, 37–46].
Fifteen (37.5%) studies were mixed methods surveys.
Eleven (27.5%) were intervention studies targeted at im-
proving private practitioners participation in disease
control programs [11, 17, 21, 22, 28, 29, 40, 41, 47–49].
Nine studies (22.5%) used secondary record review to
evaluate disease notification, and four (10%) of them
were Knowledge Attitude and Practice (KAP) surveys.
The average private practitioner response rate (in 20
studies) was 78% and ranged from 1.5% in Nigeria [50]
to 100% in Iran [51], Bangladesh [46], and Uganda [52].
Three studies from India [29, 30, 37] reported a higher
response rate to interviews compared to requests of rec-
ord reviews.
All except one study [34] referred to communicable
diseases (STIs, malaria, typhoid, influenza and five stud-
ies [26, 33, 51–53] with multiple diseases) and a majority
(28, 70%) were related to tuberculosis. Eighteen studies
(45%) refereed to laboratory confirmed case detection
and ten (25%) referred to both suspected as well as la-
boratory confirmed cases. Only one addressed syn-
dromic surveillance for influenza [54]. Eight studies
(20%) [15, 16, 27, 29–31, 52, 54] investigated private
Table 1 Overview of the studies and their main findings
No Author,
Year
Country Scale of the study Sample size Response
rate
Main findings and recommendations
1 Agrawal
et al. 2012
Malaysia Klang region 238 private practitioners 61% • Implementation of an educational
intervention to introduce details of
pharmacovigilance into in undergraduate
medical curriculum
2 Ahmadi
et al. 2012
Iran Provincial 16 disease managers for focus
groups, 9 in-depth semi-structured
interviews
100% • Establishing an appropriate and simple
notification process
• Training human resources in disease
notification
• Offering incentives, privileges, and
creating a positive perception of disease
reporting
• All solutions improve when
implemented along with a proper and
feasible law to determine the jurisdiction,
rights, liabilities, and incentives for
stakeholders
3 Ambe et al.
2005
India City: Mumbai All relevant providers in the RNTCP
by identifying suitable roles in DOTS
delivery for various providers
NA • Coordinate involvement of private
sector health care providers in an
individualized manner due the
heterogeneity of the sector
4 Arora et al.
2003
India City: three areas in
Delhi
200 patients for patient survey, 18
private practitioners; 101 cases for
treatment outcome
Not
mentioned
• Involvement of medical associations
• Funding for programmes by the
government
• Keep it simple
5 Artawan
Eka Putra
et al. 2013
Indonesia District: two
districts in Bali
181 practitioners 90.5% • Credit point system for participation
• Personal contact
• Continuous supervision
6 Barakat
et al. 2011
Morocco National 2007–08: 997 influenza cases and 403
severe acute respiratory illnesses;
2008–09: 1252 and 450 cases
respectively
NA • Important to include the private sector
in syndromic surveillance especially when
major part of care is provided by them
• Even when surveillance was enhanced
to include private practitioners the rate of
detection remained low
• Training of practitioner is necessary to
improve sensitivity and specificity of
diagnosis
7 Caminero
& Billo
2003
South
America a
National 600 private practitioners Not
mentioned
• Training is the single most important
factor
• Work towards change of attitudes
• Supervision
8 Chadha
et al. 2014
India District 8 Departments of a private medical
college, 83 nursing homes, 131
peripheral health institutes; and 1766
cases
Not
mentioned
• Awareness building
• Government rules for case notification
by private practitioners
• Assistance in diagnostics and case
notification, and documentation of
treatment outcome
9 Chakaya
et al. 2008
Kenya City: Nairobi 46 private hospitals 57% • Prepayment scheme as a case-holding
tool
10 Chengsorn
et al. 2009
Thailand National 59 public and 26 private health care
facilities and 7526 patients records.
Not
mentioned
• Academic detailing’ (university-based
educational outreach)
11 Chughtai
et al. 2013
Pakistan National Number of practitioners is not
mentioned
NA • None explicit mentioned, implicitly:
ensure continuous funding to support
disease notification
12 Creswell
et al. 2014
Pakistan City: two cities 89 GPs and one outpatient dept.
529,447 patients
Not
mentioned
• Add a new task/person or screeners in
high disease burden areas
13 Daniel
et al. 2013
Nigeria State 8425 patients registered in 2011 34% in
public and
1.5% private
• Provision of training and drugs for
involving practitioners in a TB program
(which also includes reporting activities)
14 Dowdy
et al. 2013
Pakistan City: two areas in
Karachi
TB cases: 1569 (2010) pre intervention
and 3140 (2011) post intervention; in
NA
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Table 1 Overview of the studies and their main findings (Continued)
the control area: 876 and 818 cases
in the respective years
• No recommendation on how to include
private practitioners, just underlining the
need to search for innovative approaches
15 Isabriye
2006
Uganda District 109 managers, private sector
providers and key informants
100% • Ensure that all clinics and drug shops
are registered and manned by qualified
staff.
• Identify and train nursing assistants to
carry out the IDS activities (task
shifting)Organize continuing professional
development (CPD) courses on
surveillance to improve knowledge
regularly
• Print and disseminate Information,
Education and Communication (IEC)
materials on regular basis.Regular
supervision
16 John et al.
2004
India State NA NA • With participation of private
practitioners district level disease
surveillance system was highly successful
and enabled detecting disease clustering
at the start of an outbreak
• Post card based disease reporting
method is effective for capturing clusters
of disease outbreaks
• Success factors: ease of reporting, sense
of contribution to the society, regular
feedback through monthly disease
summary bulletins
17 Khan et al.
2006
Pakistan City: two slum
areas in Lahore
5540 children 2–16 years and 5329
samples tested for microbiology
96% • Cooperation of private practitioners is
essential for complete detection of cases
18 Khan et al.
2012
Pakistan City: two areas in
Karachi
Screeners assessed 388,196
individuals at family clinics and
81,700 at Indus Hospital’s outpatient
department
NA • Engagement of intermediaries such as
community members and larger hospitals
as drivers of case detection
• Create effective links between the
public sector, private practitioners, and
communities, which may include
screening by community members and
mass communication campaigns
19 Krishnan.
2006
India Sub-district 146 private practitioners 72% • Alternative healers play important role in
India as private healthcare providers.
• Non-involvement of the informal sector
would mean large burden is missed.
• They also show greater interest in
working with the government, primarily
because it may indirectly sanction their
presence.
• Involving RMPs from urban areas had
more returns than from rural areas.
20 Lal 2011 India City: 14 cities >80,000 cases of TB NA • Up scaling of pp. involvement is
needed; crucial: continuous mapping/
registration of facilities
• Continuous training with standardised
material
• Focus on those who expressed interest
• Proactive programme officers (public
health sector)
21 Lau et al.
2011
China City: Hong Kong 247 GPs, 14 Obstetrics and
Gynecology doctors and 16 Skin and
Venereal Disease Specialists
27.6% for
GP, 11.2%
for O&B and
39.0% SVD.
• Inclusion of private practitioners in
sexually transmitted disease surveillance
systems can improve completeness and
accuracy of reported data, which has
important implications for the prevention
of such diseases
22 Masjedi
et al. 2007
Iran City: Tehran 646 cases that were diagnosed as
positive in the labs were followed up
NA • Performance of the private sector
should be regularly evaluated
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• Communications between private and
public sector should be strengthened for
better case notification
23 Maung
et al. 2006
Myanmar Division: Mandalay NA NA • Success factors in increasing case
notification through involvement of
private practitioners in case notification
were strong managerial support, a well-
developed local medical organization,
training and supervision by the public
sector, and provision of free drugs and
consumables
24 Naqui et al.
2012
Pakistan City: several towns
of Karachi
94 GPs from the selected towns, and
309 enrolled patients
37.50% • Greater regulation of private
practitioners to set standard guidelines
• Sustained government support, and a
two-way feedback mechanism from
health providers necessary
25 Newell
2004
Nepal City: Lalitpur 759 patients registered in first
24 months
67% • Not all private practitioners need to be
involved in regular surveillance.
• Sentinel surveillance can work best
involving larger hospitals
• Provide guideline booklets
26 Palave
et al. 2015
India Sub-district: Rahata,
Ahmednagar,
Maharashtra
148 private practitioners 96.6% for
visits/
interview;
89.1% for
workshop
• Strengthening of public-private partner-
ships through the provision of free mate-
rials, incentives, and periodic modular
training in disease notification and
treatment
27 Pethani
et al. 201
Pakistan City: six towns of
Karachi
94 GPs, 23 Union Councils in the 6
towns. 389 patients
Not
mentioned
• The use of contact screening to increase
further case detection by private
practitioners
• Legislative approach to enforce the
participation of private practitioners to
participate in public-private initiatives
after they have received training
28 Phalkey
et al. 2015
India City: Pune 258 private practitioners 86% • Simplified reporting mechanisms
(preferably electronic formats)
• Providing clear guidelines and reporting
procedures.
• Organizing CMEs to strengthen
practitioner knowledge and awarding
CME points to those who report cases
regularly are feasible solutions and should
be piloted
29 Philip et al.
2015
India District: Alappuzha,
Kerala
169 private practitioners in
quantitative and 34 in qualitative
component
80% for
quantitative;
94.4%
qualitative
• Consistent motivational and attitudinal
building (both private and public) to
ensure compliance
• Demonstrating disease notification as a
mode of disease control to private
practitioners
• Targeting specialists in private hospitals
for involvement in case notification
• Behavioural changes such as timely
dissemination of policy changes, and soft
skills training, and improvement of
interpersonal skills
• Involvement of a liaison officer
dedicated to public-private coordination
30 Portero
et al. 2003
Philippines National 1355 private practitioners 57.9% • Awareness building among private
practitioners (responsibility)
• Establish a network with well-trained
practitioners
• Establish clear treatment and referral
structures (also from private to public
sector in the case of TB)
31 Vietnam 30 practitioners 96.6%
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Quy et al.
2003
City: 22 districts of
Ho Chi Minh City
• Involvement of private practitioners
through training and distribution of
referral forms
• Introduction of financial incentives for
private practitioners
• Supervision of private practitioners
32 Rangan
et al. 2003
India City: Mumbai NA NA Improvement of the quality of care, e.g.,
through training in patient - health care
provider interaction
33 Sarkar et al.
2012
India Sub-district:
Alipurduar,
Jalpaiguri, West
Bengal
6191 cases of malaria; 336 cases of
severe malaria
NA • Further research to identify the reasons
for under reporting (burden of paper
work, unfamiliarity with notifiable
diseases, etc.)
• An annual review of case records at
facilities to identify unreported deaths
and enhance completeness of reporting
34 Shinde
et al. 2012
India City: seven health
posts of municipal
ward, Mumbai
104 private medical practitioners
(PMP)
Not
mentioned
• Greater emphasis by public health
agencies on legal and public health basis
for reporting conditions
• Training private practitioners to report
the presumptive as well as confirmed
cases of diseases under surveillance
• Use of appropriate software for
paperless communication in case
reporting
• Encourage the use of standard the
prescribed formats for reporting by
private practitioners
• Provision of private practitioners with
periodic telephonic communication and
alert messages regarding notification
35 Singh et al.
2015a
South
Africa
National NA NA • Considerable education and relationship
building exercises necessary
• Stakeholder consultation essential for
common understanding and shared
vision
• Large hospitals more compliant than
independent practitioners
• Despite legislation reporting is poor
• Absence of electronic data biggest
challenge
• Peer networking e.g. Senior Oncologist
to champion the cause of case reporting
•
36 Srivastava
et al. 2011
India District: Gwalior 200 allopathic private practitioners Not
mentioned
• Regular upgrade in knowledge
• Provision of additional benefits to the
private practitioners to increase the rates
of notification
37 Tan et al.
2009
Taiwan National 15 of 26 counties/cities selected,
1093 private practitioners
87.4% • Modify doctor’s attitude to disease
reporting
• Developing a convenient and widely-
accepted reporting system (phone report-
ing where possible)
• Establishing reward/penalty system
essential in improving reporting
compliance in private doctors.
38 Yeole et al.
2015
India City: Pimpri
Chinchwad
Municipal
Corporation(PCMC)
area, Pune
831 for the quantitative, 24 for
qualitative
64% for
quantitative
and 100%
qualitative
• Provision of training for private
practitioners
• Targeted media communication
campaigns
• Establish alternative mechanisms for
notification (to facilitate notification), e.g.,
internet and mobile telephones, to save
the time spent on notification
39 Ethiopia Region: Amhara 112 private practitioners 77% • Regular training
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Yimer et al.
2012
• Feedback and mutual information
between private sector and referral
institutions in the public sector
40 Zafar Ullah
et al. 2012
Bangladesh City: four areas in
Dhakacity; later
scaled up to
twomajor cities
97 PMPs in 2004, 703 at the end of
2009
100% • Provision of training
• Provision of tools and protocols
• Mutual trust
aMexico, El Salvador, Honduras, Guatemala, Nicaragua, Peru, Dominican Republic, Costa Rica, Bolivia
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reporting. Thirteen (32.5%) [17, 24, 28, 34, 37, 38, 40, 41,
44, 50, 53, 55, 56] investigated systems that expected
mandatory case reporting from the private sector.
Fifteen studies (15, 37.5%) [16, 22, 25, 27, 28, 34, 38, 40,
43, 45, 46, 48, 55, 57, 58] stated that involving private
sector reduced diagnostic delays and improved case de-
tection (7 to 50%). Even when only a fraction of private
practitioners became active, the case detection rose sig-
nificantly [22]. Involving the private practitioners in sur-
veillance activities also helped identify an emerging
disease (leptospirosis) in India [26], recognize patterns in
health seeking behaviors in China [42], Nigeria [50], and
Morocco [54] and detect comorbidities in Kenya [38].
Barriers to notification
Eight (20%) [15, 16, 30, 33, 37, 49, 51, 53] studies identi-
fied knowledge of the practitioner as the most important
determinant of case detection, confirmation and notifi-
cation (Table 3A). Knowledge about disease control pro-
grams and their diagnostic requirements was higher
amongst public as compared to private practitioners [36].
Although the knowledge regarding disease detection was
lower amongst alternate medicine practitioners as com-
pared to allopath practitioners in India, the surveillance
practices did not differ significantly [14]. General practi-
tioners were more likely to be aware about the importance
of notification than specialists in India [29, 30] and
Malaysia [15]. The duration (>5 years) of practice (OR
11.4, 95% CI 1.99, 65.58, p = 0.001) was significantly asso-
ciated with practitioner reporting in Uganda [52]. In
Malaysia, practitioners were willing to report cases only
when they were confident of their diagnosis [15].
Apart from disease knowledge a clear understanding
of the notification procedures is critical to reporting.
Lack of clear instructions, inadequate dissemination of
guidelines and no assistance with reporting procedures,
supervision or feedback were identified as the most im-
portant reasons for under reporting in nine studies
(22.5%) [14, 22, 24, 33, 34, 43, 46, 48, 51] (Table 3B).
Over 50% of the 238 practitioners in the study from
Malaysia did not know whom to report to and did not
have reporting forms [15]. In Uganda about half (49%)
of the 109 practitioners knew where to send the report
but only 21% (n = 23) knew which form to use [52].Practitioners who considered the system inconvenient or
were unfamiliar with the reporting procedures were less
likely to report cases in Taiwan [53].
Simplicity of reporting procedures and the mode of
reporting offered (telephone, email, paper etc.) were im-
portant determinants in India [33] and Taiwan [53].
Findings from Bangladesh [46] and India [37] indicate
that reporting compliance increases over time as the fa-
miliarity to the system grows and therefore sustained ef-
forts are necessary. The rated public health importance
of the disease (e.g. cholera > enteric fever) or sense of
emergency (e.g. Zika) also affects disease notification
from the private practitioners [26].
Appreciating the importance of surveillance or ad-
equate knowledge of the disease and its reporting proce-
dures does not ensure case notification. Two studies in
India suggested that only about half of the practitioners
who understood the importance of notification agreed to
report/participate in surveillance activities [30, 33]. Yeole
et al. (2015) support these findings [37] where although
64% of 831 practitioners agreed to participate in a sur-
veillance system, only 16% (n = 87) actually notified data.
Although about half of the participants (104, 46%) in a
study in Mumbai said that there were no barriers to
reporting, this was not reflected in their reporting prac-
tices [33].
The attitude of the practitioners was reported as sig-
nificant determinant of case notification in studies from
Malaysia [15], India [36], and Uganda [52].
Of the 238 practitioners in a study in Malaysia, 73.1%
exhibited unsatisfactory “attitude” towards disease notifi-
cation, 81.9% showed complacency, 66.9% ignorance and
23.5% indifference respectively [15]. Ullah et al. (2012)
report it was the negative attitudes of the practitioners to-
wards the government officials rather than the notification
process itself that affected reporting in Bangladesh [46].
Ahmadi et al. (2013) note that it was the negative attitude
of the data collectors towards data compilation and to-
wards the practitioners, which discouraged practitioners
from notification in Iran [51].
Lal et al. (2011) and Ambe et al. (2005) conclude that
there is mutual distrust and prejudices and suggest that
trust building is necessary at both the public and private
practitioners end alike. Seven (17.5%) studies [14, 22, 30,
37, 46, 48, 51] and six (15%) studies [28, 31, 34, 48, 55, 59]
Table 2 Overview of the supporting studies
No Author, Year Country Main findings and recommendations
1 Arora and Gupta,
2002
India • Formats for record keeping at a private health facility should be simple and concise
• Laboratories should be identified within or in the vicinity of private health facilities.
• Expertise enhanced via appropriate training programs
• Multiple awareness-campaigns are necessary
• State must provide incessant administrative and a financial support to both public and private sectors
2 Chitkara et al.
2013
India • Limited awareness in private sector with regards to reporting
• Interaction with professional bodies
• Stronger collaboration between governments and professional bodies and the private sector
• Sensitizing private sector through professional body meetings
• Dissemination of information through professional body publications
• Online reporting platform
• Integrated voice recording and SMS reporting
• Inculcate confidence
3 Dewan et al.
2006
India • Private sector involvement in surveillance is feasible and cost-effective
• Professional societies such as Indian Medical Association are essential partners in bringing together public and
private sectors
• Advocacy, training, supervision are necessary to maintain interest of the private sector
4 Kirsch & Harvey,
1994
Global • Private practitioners fail to report cases because of ignorance on reporting requirements and procedures
• Patient confidentiality
• Perceptions that reporting is time consuming, motivation and excessive workloads
• Reasons are similar to public sector
• Underfunding, under staffing and lack of supervision main determinants for under reporting
• Remove obstacles to reporting
• Only relevant data to be collected, checklist rather than forms
• Clear contact person
• Incentives in form of recognition from professional bodies, free laboratory reagents, journal subscriptions etc.
5 Lei et al. 2015 Global • Multiple collaborative mechanisms promote case detection, confirmation and reporting
• Incentives e.g. free tests and drugs are useful approach to improve private sector participation
• Regulations should be enforced punishment for non reporting also adopted
• Compulsory to improve the knowledge, consciousness and behavior of the practitioners
• Training courses should enforce an exam that needs to be passed
• Better governance from the program managers and the government
• Lack of communication and mistrust reduces mutual understanding between the public and private sectors
6 Revankar, 2004 India • Simplify guidelines
• Provide technical assistance to the practitioners
• Provide financial assistance for capacity building within the private sector
• Establishing partnerships is difficult sustaining them even bigger challenge
• Heavy inputs from the governments necessary
• Motivation and interests of the private practitioners difficult to monitor and sustain
7 Nagaraja et al.
2014
Global • Raise awareness amongst private practitioners regarding surveillance
• Regular media campaigns and advocacy to sustain interest
• Strong regulatory and punitive action for non reporting
• Including private sector without legal back up is difficult
• Governments should consider providing infrastructural support such as handheld devices
• Use friendly and simple notification as per practitioner preference
• Varied reporting formats to be accepted simple web based application, SMA, toll free number or paper based
reporting as per practitioner preference
8 Uplekar et al.
2001
Global • Sensitization of the private sector essential
• Training is essential to improve case detection, confirmation and notification
• Signing of Memorandum of Understanding (MOU) and letter of agreements
• Concerted efforts sustained overtime necessary
9 Uplekar, 2003 Global • Improved role for the government in providing information, regulation and financing of trainings for private
sector
• Revamping UG and PG medical curricula to enhance record keeping practices
• Teaching hospitals as essential links between public and private sectors
• Telephone line and onsite visits for trouble shooting
• Bilateral visits to understand the work of the other (public and private sectors)
• Mutual respect, working through consensus and inclusion of private sector in policy making can improve
compliance
• Problems identified
✓ Public sector: lack of will to take on private sector, preoccupied with several programs, believe eventually
patients will come to them, little common ground for collaboration with heterogeneous, unregulated private
sector, in the absence of regulation view them as unmanageable
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Table 2 Overview of the supporting studies (Continued)
✓ Private sector: absence of information, do not agree with national guidelines as they ate not a part of making
them, critical of distrust shown towards them, reluctant to loose their patients
10 WHO, 2015 Global • NGOs and private labs are useful intermediary institutions
• Public and private partnerships can be win-win partnerships for all stakeholder when implemented well
• Include private sector on discussion boards of national committees
• Monthly face to face meetings build trust
• Mandatory regulations to ensure compliance
• Professional bodies and role models can be used to improve practitioner reporting
Table 3 Barriers to case reporting at the practitioner and government/public sector end as identified by the studies
A Barriers to reporting: practitioner end n %
1 Knowledge
Lack of information what, how, where to report /unfamiliarity
on reporting process/system [15, 16, 30, 33, 37, 49, 51, 53]
8 (20%)
2 Attitudes
Motivation [11, 14, 51, 59] and lethargy [15] 5(12.5%)
Should be financially reimbursed [15, 27] 2 (5%)
Disease reporting not considered a priority [51] 1 (2.5%)
3 Perceptions
Patient confidentiality [14, 15, 30, 34, 37, 53, 56] 8 (20%)
Legal issues [14, 15, 33, 51] 4 (10%)
Complicated reporting systems [37, 51, 53] 3 (7.5%)
Fear of losing patients [16, 28] 2 (5%)
Beyond scope of clinicians responsibilities /No obvious
benefit [11, 51]
2 (5%)
Misconception about reporting procedures [30] 1 (2.5%)
Appear foolish if misdiagnosed [15] 1 (2.5%)
Fear notification may trigger further investigations [15] 1 (2.5%)
4 Practice
Infrastructure issues such as human (adequate and skilled, staff turnover)
resources and equipment resources [14, 17, 27, 31, 32, 48, 50, 51, 58]
9 (22.5%)
Lack of time/additional burden [14–17, 33, 34, 53] 7 (17.5%)
Lack of reporting forms/registers [15, 37] impractical design [15] 3 (7.5%)
No lab or technician [11, 26, 48] 3 (7.5%)
Cost of reporting [59] 1 (2.5%)
B Barriers to reporting: government and public sector end n %
Lack of clear instructions/inadequate dissemination of guidelines/no
assistance with reporting procedures, supervision or feedback etc.
[14, 22, 24, 33, 34, 43, 46, 48, 51]
9 (22.5%)
Lack of cooperation/coordination/collaborative environment/positive
dialogue (Govt. and private sectors) [14, 22, 30, 37, 46, 48, 51]
7 (17.5%)
Lack of leadership/strong and proactive administration [28, 31, 34, 48, 55, 59] 6 (15%)
No punitive action or regulation [11, 22, 30, 53]
(separate regulatory function from service provision [27])
5 (12.5%)
Non-involvement of range of private healthcare providers [11, 22, 27] 3 (7.5%)
Other (Red tapism [33], lack of simplified system [37] 2 (5%)
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the government and the private sector as the main barrier
for case reporting respectively (Table 3B). There is a need
for managing perceptional conflicts at both ends [30].
While the government sector should attract and sustain
private practitioner attention, the private practitioners
should exhibit their responsibility towards disease notifi-
cation [22, 28]. Five (12.5) studies [11, 14, 15, 51, 59] sug-
gest that the motivation of the practitioners also played an
important role in disease notification.
While eight studies (20%) [14, 15, 30, 34, 37, 53, 56]
and four (10%) studies [14, 15, 33, 51] identified breach
of patient confidentiality and legal issues as reasons for
not reporting respectively, Philip et al. (2015) suggest
this is a perception only as legal frameworks in most
countries allow case notification to governments [30].
Nine (22.5%) studies [14, 17, 27, 31, 32, 48, 50, 51,
58] reported the lack of adequate and skilled staff
and equipment (e.g. computers) as the main barriers
to case reporting. Interestingly only seven (17.5%)
studies [14–17, 33, 34, 53] identified lack of time as the
main barrier. While the maintenance of records within in-
dividual facility was significant determinant of case notifi-
cation in Ethiopia [60], the availability of information
materials, registers and reporting formats affected case
reporting in Uganda [52]. Access to a laboratory (OR 3.79,
95% CI 0.99, 14.55, p = 0.05) played an important role in
the willingness of private practitioners to report cases in
India [17].
Recommendations to improve reporting
Obtaining an overview of the private sector by identifying
the different actors and clearly stating their roles and re-
sponsibilities was recommended as the first step towards
government regulation of the private sector (Table 4) with
regard to disease surveillance [11, 22, 27, 28, 31, 45, 52].
Krishnan et al. (2006) suggest a separation of the govern-
ments’ regulatory function from public service provision
to ensure strict action against reporting defaulters [27].
Eight studies each recommended standardization of uni-
fied reporting procedures [11, 22, 31, 33, 46, 48, 51, 57]
and earmarked public financial resources for capacity
building within the private sector for disease surveillance
[14, 17, 21, 23, 31, 40, 52, 55].
At the district administration level, the main recom-
mendation was to provide surveillance training (regular
[14, 15, 21, 25, 28–31, 33, 34, 36, 46, 48–52, 55, 57, 60]
and continuing medical education [14, 29, 30, 36, 37]).
Five (12.5%) studies recommended revision of regular
undergraduate and postgraduate medical curricula to in-
corporate a stronger focus on surveillance activities [15,
28, 29, 51, 57]. Eleven (27.5%) studies [16, 29, 31, 34, 36,
37, 40, 50, 52, 57, 60] recommended that IEC materials
and guidelines should be widely disseminated. Eleven(27.5%) studies [27, 30, 32–34, 37, 43, 45, 46] recom-
mended improving the communication between the gov-
ernment, public and private sectors (Table 4).
At the program level, feedback (10, 25% studies) [11,
14, 16, 17, 26, 27, 31, 45, 46, 52] and supportive supervi-
sion (9, 22.5% studies) [25, 27, 33, 45, 46, 48, 49, 51, 52]
were the main recommendations. Eight studies (20%)
[14, 16, 17, 27, 29, 40, 51, 53] recommended that in the
absence of regulation there may be the need to provide
an incentive/reward (e.g. CME credits) for reporting.
Only one study suggested that the incentives could be
non-financial (e.g. technical assistance, supervision, free
diagnostics etc.) [14, 18].
Discussion
Findings of the review suggest that the knowledge, atti-
tudes, perceptions, and practices of the government, the
public sector practitioners (who implement surveillance
programs), and the private sector practitioners affect
case notification. Interventions targeting all three groups
are therefore mandated. Training, timely feedback, and
regular supportive supervision from the program man-
agers can improve case notification. Simple standardized
reporting procedures with clear guidelines and effective
communication between those providing and receiving
the data are key to effective private practitioner partici-
pation in disease surveillance. More importantly regular
publication of disease data from both public and private
sectors can encourage reporting as it serves as feedback
to those reporting. Improved representativeness serves
as evidence base and aids the use of data for decision
making at the national levels.
The factors affecting case reporting from the private
practitioners as identified in this review are similar to
those reported for under reporting from the public sec-
tor within the Integrated Disease Surveillance and Re-
sponse systems (IDSR) which collect routine data mainly
from the public sector [61, 62]. Therefore an important
first step would be to make the distinction between the
roles of the policy makers, healthcare providers and
people (individual practitioners)! There is the urgent
need to separate the words public sector and govern-
ment [27]. While public sector facilities and practitioners
funded through general taxes are responsible for imple-
menting disease control programs in most LMICs, the
role of the government is wider. Governments bear the
responsibility to regulate and develop both the public as
well as the private sectors equally [5]. All data collection
should be substantiated with follow up action in order
to encourage reporting compliance in both the public
and private sectors. Furthermore involvement of the end
users (patients and communities), non-government and
civil advocacy organizations should be considered to cre-
ate enabling environments for disease data reporting.
Table 4 Recommendations to improve private practitioner participation in disease surveillance
National government level No of Studies (%)
1 Registration and regulation of the private sector [11, 22, 28, 31, 45, 52]
Involvement of wide range of healthcare providers [11, 22, 27]
9 (22.5%)
2 Standardized reporting procedures with roles and responsibilities clearly
stated [11, 22, 31, 33, 46, 51, 57]
Unified recording and reporting system [48]
8 (20%)
3 Financial (earmarked funds for private sector) and human resource
assistance from public sector [17, 31, 52, 55] and funds for training [14, 21, 23, 40]
8 (20%)
4 Establish surveillance legislation/legal frameworks [17, 33, 34]
Stakeholder consultation in policy making [34, 42, 46]
6 (15%)
5 Credit point system for participation [33, 36, 49]
Comparable measurable performance indicators and audits [30, 32, 51]
6 (15%)
6 UG and PG medical curricula [15, 28, 29, 51, 57] 5 (12.5%)
7 Mandatory notification [14, 26, 30] 3 (7.5%)
District and local administrative level
1 Staff and practitioner training [14, 15, 21, 25, 28–31, 33, 34, 36, 46, 48–52, 55, 57, 60]
CME [14, 29, 30, 36, 37]
25 (62.5%)
2 Dissemination of information, IEC materials, mass communication campaigns
[16, 29, 31, 34, 36, 37, 40, 50, 52, 57, 60]
11 (27.5%)
3 Establish and strengthen formal collaborations [27, 45]
Communication with practitioners [30, 32, 33, 43]
Leadership [59]
Strong and proactive administration [28, 48]
9 (22.5%)
4 Simplified reporting procedure [14, 32, 33, 37, 51, 53, 55] 7 (17.5%)
5 IMA (interface organizations assistance) [25, 29, 31, 48, 55] 5 (12.5%)
6 Provide reporting forms/appropriate softwares [33, 45, 49] [26] 4 (10%)
Surveillance program level
1 Feedback (summary bulletins, review meetings etc.) [11, 16, 17, 26, 27, 31, 45, 46, 52]
Acknowledgement of efforts [14]
10 (25%)
2 Supportive supervision and visits onsite [25, 27, 33, 45, 46, 48, 49, 51, 52] 9 (22.5%)
3 Financial incentives [16, 17, 27, 29, 40, 51]
Reward and penalty system [53]
Non cash incentives [14]
8 (20%)
4 Allow diverse reporting mechanisms to overcome perceived barriers [11, 30, 33, 37, 53, 58] 6 (15%)
5 Technical assistance [31, 45]
Laboratory services [24, 45, 49]
5 (12.5%)
6 Personal contact/ relationship and trust building [27, 33, 34, 37, 46] 5 (12.5%)
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size, arrangements and functionality of the informal sectors
[40] are probably the main reasons why it is a resource and
logistical challenge to regulate the private sector in most
LMICs [31]. Often records of all healthcare providers are
not available even with the government which is a challenge
for assessing reporting consistency and disease burdens
[14]. Governments should exercise authority and use regis-
tration as a tool to regulate the formal private sector fa-
cilities as a start. Although troublesome to implement, a
“single registration platform” for all providers should be ad-
vocated to record the legal status, size, and nature of ser-
vices provided [63]. Stronger legislative and regulatoryframeworks are necessary to harmonize the diverse set of
stakeholders [6, 17].
The next step would be to simplify and standardize
the reporting procedures, provide clear guidelines and
ensuring that the information reaches every intended
private practitioner [18, 64]. Where possible, data
should be obtained in a format (email, toll free num-
ber, text-messages, paper forms etc.) preferable to the
practitioner and without incurring extra work or
interrupting workflows [33]. Private sector should be
involved in decision-making processes with regards to
surveillance and invited to become members of na-
tional policy implementation boards [13, 65].
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should be seen as important as in the public sector.
Governments should invest in the training of private
practitioners (CME, workshops etc.) and accessory staff
in surveillance procedures. Medical curricula should be
revisited to emphasize the importance of reporting [13].
A substantial “knowledge-application/practice gap” ex-
ists and even amongst practitioners who know and
understand the importance of reporting only about a
half will notify [17]. Therefore intermittent sensitization
campaigns highlighting the importance and processes of
surveillance are useful [66]. Small individual clinics con-
stitute a major proportion of the private sector and the
public sector should have sufficient capacity to train and
supervise the large (and growing) numbers [59].
In addition, supportive supervision through onsite visits
by program officers facilitate trust building and should be
implemented [67]. While this is resource intensive, exten-
sive initial input followed by regular follow up pays off in
the long run [37, 46]. “Without feedback, practitioners soon
realize that it makes no difference whether they report. In-
formation is of value only when it is used for decision-
making” [68]. Regular feedback (telephone, newsletter, re-
view meetings etc.) is an essential determinant of provider
motivation and should be mandatorily provided [69–71].
Four [35, 72–74] studies suggested that reporting
should be mandatory and a penalty be imposed for non-
reporting. However voluntary systems are more accurate
and although legal obligation evokes reporting, reporting
is more complete when the practitioner understands the
importance of sending reports [75, 76]. Six studies [16,
17, 27, 29, 40, 51] from India, Iran and Pakistan sug-
gested that in the absence of regulatory frameworks fi-
nancial incentives may become necessary for consistency
in voluntary reporting. While there are fundamental dif-
ferences in the values of individuals in the not for profit
public and the only for profit private sectors that are dif-
ficult to navigate, this approach is not sustainable [77].
Awarding non-financial incentives such as free training,
credit points towards Continuing Medical Education
(CME) for consistent reporting, free drugs, laboratory tests,
and access to scientific journals or books etc. may be of-
fered. Infrastructure assistance such as software loaded
basic handheld devices with a direct reporting tools could
be an option for the future [5, 66]. Alternately commission-
ing surveillance from large private hospitals with closely
monitored contracts and performance-based incentives
may prove beneficial [6]. Once routine data reporting im-
proves, efforts to investigate the quality of the data received
from private sector and comparative assessments between
public and private providers could be useful.
The links between the governments, public, and private
sectors need to be identified and strengthened. Intermedi-
ary bodies such as Non-Governmental Organizations [25,28, 31], professional associations [25, 64], private labs [35,
78], private medical colleges [13], and pharmacies [73, 74]
are crucial connectors and can facilitate communication
between the three groups [35, 72–74]. Practitioners in
LMICs often work in both the public and private sectors.
Those with dual roles could be roped in to initiate a dia-
logue with the private sector and also promote peer
reporting from defaulting practitioners [65]. Practitioners’
ranking based on consistency in routine disease data
reporting has been attempted within the Integrated infec-
tious Disease Surveillance and Response system (IDSR) in
India and could be tested at scale in other settings. Most
importantly all actors need to acknowledge the overarch-
ing role of the government to regulate and support them
at the same time. Sharing of knowledge and best practices
alongside skills transfer should be encouraged across re-
gional and national governments in order to avoid delays
in implementing changes already tried and successful in
better involvement of the private sector in routine disease
surveillance.
Conclusion
The current private practitioner participation in disease
surveillance efforts is appalling. The main barriers to their
participation are inadequate knowledge leading to unsatis-
factory attitudes and misperceptions that influence their
practices. Complicated reporting mechanisms with unclear
guidelines along with unsatisfactory attitudes on behalf of
the government also contribute to the under reporting. In-
frastructural barriers such as availability of computers and
human resources need rectification. Governments need to
take leadership and foster collaborative partnerships be-
tween public and private sectors for routine disease surveil-
lance and exercise authority when needed. Surveillance
program officers need to provide periodic training, offer
supportive supervision and regular feedback to practi-
tioners from both public as well as private sectors.
Additional file
Additional file 1: Provides an overview of the search strategy and
search terms by databases used for the review. (DOCX 140 kb)
Abbreviations
CDC: Centers for Disease Control; CME: Continuing Medical Education;
DFG: Deutsches Forschungsgemeinschaft (German Research Foundation);
LMICs: Low and Middle Income Countries; NGOs: Non Government
Organizations; OR: Odds Ratio; WHO IRIN: WHO Global Digital library;
WHOLIS: WHO Library database
Acknowledgements
We would like to thank Mr. Fredrick Daniel Isabirye and Dr. Peter Waiswa at
the Makrere University, Uganda for sharing the relevant unpublished thesis.
Funding
The work was supported by the German Research Foundation (DFG)
(grant number KR1764/17–1).
Phalkey et al. BMC Health Services Research  (2017) 17:599 Page 14 of 15Authors’ contributions
RP conceptualized and designed the study; extracted, analysed and
interpreted the data; wrote first draft and revised the manuscript. CB and KB
reviewed the full texts and contributed to the data extraction. MK and FK
participated in the design of the study. All authors read, approved and
provided comments for revision of the manuscript.
Ethics approval and consent to participate
Not applicable as this is a systematic review paper. However this work was
conducted within the German Research Council funded project. Ethical
approvals for empirical work within the project were obtained from the
Ethical approval was received from the Ethics Commissions of the Faculty of
Medicine of Cologne University, Germany (No. 13–107) and from the
Institutional Ethics Committee Bharati Vidyapeeth Deemed University, Pune/
India (No. IEC/2013–14/40).
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Division of Epidemiology & Public Health, University of Nottingham, C111,
Clinical Sciences Building 2, City Hospital, Hucknall Road, NG5 1PB
Nottingham, Nottingham, UK. 2Institute of Public Health, University of
Heidelberg, Im Neuenheimer Feld 130.3, 69120 Heidelberg, Germany.
3Institute of Geography, University of Cologne, Albertus-Magnus-Platz,
D-50923 Cologne, Germany. 4London School of Hygiene and Tropical
Medicine (LSHTM), 15-17 Tavistock Place, WC1H 9SH, London, UK.
Received: 28 September 2016 Accepted: 27 July 2017
References
1. Gostin LO, Lucey D, Phelan A. The Ebola epidemic: a global health
emergency. JAMA. 2014;312(11):1095–6.
2. O'Hare B. Weak health systems and Ebola. Lancet Glob Health. 2015;3(2):e71–2.
3. Castro MC. Zika virus and health Systems in Brazil: from unknown to a
menace. Health Syst Reform. 2016. doi:10.1080/23288604.2016.1179085.
4. Gostin LO. Ebola: towards an International Health Systems Fund. Lancet
(London, England). 2014;384(9951):e49–51.
5. Sood N, Burger N, Yoong J, Kopf D, Spreng C. Firm-level perspectives on
public sector engagement with private healthcare providers: survey
evidence from Ghana and Kenya. PLoS One. 2011;6(11):e27194.
6. Sinanovic E, Kumaranayake L. The motivations for participation in public-
private partnerships for the provision of tuberculosis treatment in South
Africa. Glob Public Health. 2010;5(5):479–92.
7. Hanson K, Berman P. Private health care provision in developing countries:
a preliminary analysis of levels and composition. Health Policy Plan. 1998;
13(3):195–211.
8. Dhawan A. New Delhi: Deloitte India. 2015. Available at https://www2.
deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-
Care/gxlshc-2015-health-care-outlook-india.pdf. Accessed 7 May 2016.
9. UN. World Urbanization Prospects: The 2014 Revision, Highlights (ST/ESA/
SER.A/352). New York: United Nations, Department of Economic and Social
Affairs, Population Division; 2014. Available at http://esa.un.org/unpd/wup/
Publications/Files/WUP2014-Highlights.pdf. Accessed 25 Apr 2016.
10. UN. World population projected to reach 9.7 billion by 2050. 2015. http://
www.un.org/en/development/desa/news/population/2015-report.html.
Accessed 25 Apr 2016.
11. Naqvi SA, Naseer M, Kazi A, et al. Implementing a public-private mix model
for tuberculosis treatment in urban Pakistan: lessons and experiences. Int J
Tuberc Lung Dis. 2012;16(6):817–21.
12. Reddy KS. India's aspirations for universal health coverage. N Engl J Med.
2015;373(1):1–5.
13. Uplekar M, Pathania V, Raviglione M. Private practitioners and public
health: weak links in tuberculosis control. Lancet (London, England).
2001;358:912–6.14. Phalkey RK, Kroll M, Dutta S, et al. Knowledge, attitude, and practices with
respect to disease surveillance among urban private practitioners in Pune.
India. 2015;2015:8.
15. Agrawal R, Daher AM, Islail NM. Knowledge, practices and attitudes towards
adverse drug reaction reporting by private practitioners from Klang Valley in
Malaysia. Malaysia J Med Sci. 2013;20(2):52–61.
16. Khan MI, Sahito SM, Khan MJ, et al. Enhanced disease surveillance through
private health care sector cooperation in Karachi, Pakistan: experience from
a vaccine trial. Bull World Health Organ. 2006;84(1):72–7.
17. Pethani A, Zafar M, Khan AA, Rabbani Sana U, Ahmed S, Fatmi Z. Engaging
general practitioners in public-private mix tuberculosis DOTS program in an
urban area in Pakistan: need for context-specific approach. Asia Pac J Public
Health. 2015;27(2):NP984–NP92.
18. Revankar CR. Public-Private Partnership Iin Public Health Programmes in
India. Mumbai: Health Program management; 2004. Available at http://
medind.nic.in/haa/t08/i1/haat08i1p24.pdf. Accessed 25 Apr 2016.
19. Moher D, Liberati A, Tetzlaff J, Altman D. The PRISMA Group (2009).
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The
PRISMA Statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535.
20. The World Bank. Country Economic Categories. 2016. http://data.worldbank.
org/about/country-and-lending-groups. Accessed 7 May 2016.
21. Caminero JA, Billo NE. Involving private practitioners and chest physicians in
the control of tuberculosis. Tuberculosis. 2003;83(1–3):148–55.
22. Ambe G, Lönnroth K, Dholakia Y, et al. Every provider counts: effect of a
comprehensive public-private mix approach for TB control in a large
metropolitan area in India. Int J Tuberc Lung Dis. 2005;9(5):562–8.
23. Arora VK, Sarin R, Lönnroth K. Feasibility amd effectiveness of a public-
private mix project for improved TB control in Delhi, India. Int J Tuberc
Lung Dis. 2003;7(12):1131–8.
24. Chadha VK, Praseeja P, Gupta J, et al. A descriptive study of tuberculosis
case finding in private health care facilities in a south Indian district. Int J
Tuberc Lung Dis. 2014;18(12):1455–8.
25. Dewan PK, Lal SS, Lonnroth K, et al. Improving tuberculosis control through
public-private collaboration in India: literature review. BMJ (Clinical research
ed). 2006;332(7541):574–8.
26. John TJ, Rajappan K, Arjunan KK. Communicable diseases monitored by
disease surveillance in Kottayam district, Kerala state, India. Indian J Med
Res. 2004;120(2):86–93.
27. Krishnan A, Kapoor SK. Involvement of private practitioners in tuberculosis
control in Ballabgarh, northern India. Int J Tuberc Lung Dis. 2006;10(3):264–9.
28. Lal SS, Sahu S, Wares F, Lönnroth K, Chauhan LS, Uplekar M. Intensified
scale-up of public-private mix: a systems approach to tuberculosis care and
control in Inida. Int J Tuberc Lung Dis. 2011;15(1):97–104.
29. Palve BS, Parkhad SB, Phalke VD, Phalke DB. Strategy to increase awareness
and involvement of private medical practitioners in RNTCP in taluka Rahata
of district Ahmednagar. J Clin Diagn Res. 2015;9(2):LC10–LC4.
30. Philip S, Isaakidis P, Sagili KD, Meharunnisa A, Mrithyunjayan S, Kumar AMV.
“they know, they agree, but they don't do” - the paradox of tuberculosis
case notification by private practitioners in Alappuzha district, Kerala, India.
PLoS One. 2015;10(4):1–13.
31. Rangan S, Ambe G, Borremans N, Zallocco D, Porter J. The Mumbai
experience in building field level partnerships for DOTS implementation.
Tuberculosis. 2003;83(1–3):165–72.
32. Sarkar J, Shah NK, Murhekar MV. Incidence, management, and reporting
of severe and fatal plasmodium falciparum malaria in secondary and
tertiary health facilities of Alipurduar, India in 2009. J Vector Borne Dis.
2012;49(3):157–63.
33. Shinde RR, Kembhavi RS, Kuwatada JS, Khandednath TS. To develop a public
private partnership model of disease notification as a part of integrated
disease surveillance project ( IDSP ) for private medical practitioners in Mumbai
City, India. Glob J Med Public Health. 2012;1(6):1–11.
34. Singh E, Ruff P, Babb C, et al. Establishment of a cancer surveillance
programme: the south African experience. Lancet Oncol. 2015;16(8):
e414–e21.
35. Singh E, Underwood JM, Nattey C, Babb C, Sengayi M, Kellett P. South
African national cancer registry: effect of withheld data from private health
systems on cancer incidence estimates. S Afr Med J. 2015;105(2):107–9.
36. Srivastava DK, Mishra A, Mishra S, et al. A comparative assessment of KAP
regarding tuberculosis and RNTCP among government and private
practitioners in district Gwalior, India: an operational research. Indian J
Tuberc. 2011;58(4):18–177.
Phalkey et al. BMC Health Services Research  (2017) 17:599 Page 15 of 1537. Yeole RD, Khillare K, Chadha VK, Lo T, Kumar AMV. Tuberculosis case
notification by private practitioners in Pune, India: how well are we doing?
Public Health Action. 2015;5(3):173–9.
38. Chakaya J, Uplekar M, Mansoer J, et al. Public-private mix for control of
tuberculosis and TB-HIV in Nairobi, Kenya:outcomes, opportunities and
obstacles. Int J Tuberc Lung Dis. 2008;12(11):1274–8.
39. Creswell J, Khowaja S, Codlin A, et al. An evaluation of systematic tuberculosis
screening at private facilities in Karachi. Pakistan PloS one. 2014;9(4):e93858.
40. Dowdy DW, Lotia I, Azman AS, Creswell J, Sahu S, Khan AJ. Population-level
impact of active tuberculosis case finding in an Asian megacity. PLoS One.
2013;8(10):e77517.
41. Khan AJ, Khowaja S, Khan FS, et al. Engaging the private sector to increase
tuberculosis case detection: an impact evaluation study. Lancet Infect Dis.
2012;12(8):608–16.
42. Lau JTF, Lin C, Ho KM, et al. Setting up a surveillance system for sexually
transmitted diseases in the general population with prospective data
collection from private-practice and public-practice doctors in Hong Kong.
BMC Public Health. 2011;11(1):254.
43. Masjedi MR, Fadaizadeh L, Taghizadeh AR. Notification of patients with
tuberculosis detected in the private sector, Tehran, Iran. Int J Tuberc Lung
Dis. 2007;11(8):882–6.
44. Newell JN, Pande AB, Baral SC, Bam DS, Malla P. Control of tuberculosis in
an urban setting in Nepal: public–private partnership. Bull World Health
Organ. 2004;82(2):92–8.
45. Quy HT, Lan NTN, Lönnroth K, Buu TN, Dieu TTN, Hai LT. Public-private mix
for improved TB control in ho chi Minh City, Vietnam: an assessment of its
impact on case detection. Int J Tuberc Lung Dis. 2003;7(5):464–71.
46. Zafar Ullah AN, Huque R, Husain A, Akter S, Islam A, Newell JN.
Effectiveness of involving the private medical sector in the national TB
control Programme in Bangladesh: evidence from mixed methods. BMJ
Open. 2012;2(6):1–8.
47. Chakaya J, Uplekar M, Mansoer J, et al. Public-private mix for control of
tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and
obstacles. Int J Tuberc Lung Dis. 2008;12(11):1274–8.
48. Maung M, Kluge H, Aye T, et al. Private GPs contribute to TB control in
Myanmar: evaluation of a PPM initiative in Mandalay division. Int J Tuberc Lung
Dis. 2006;10(9):982–7.
49. Artawan Eka Putra IW, Utami NW, Suarjana IK, et al. Factors associated to
referral of tuberculosis suspects by private practitioners to community health
centres in Bali Province, Indonesia. BMC Health Serv Res. 2013;13:445.
50. Daniel OJ, Adedeji Adejumo O, Abdur-Razzaq HA, Ngozi Adejumo E,
Salako AA. Public-private mix for TB and TB-HIV care in Lagos, Nigeria.
Int J Tuberc Lung Dis. 2013;17(9):1195–8.
51. Ahmadi A, Nedjat S, Gholami J, Majdzadeh R. Disease surveillance and
private sector in the metropolitans: a troublesome collaboration. Int J Prev
Med. 2013;4(9):1036–44.
52. Isabriye D. Factors associated with participation of private medical
practitioners in integrated disease surveillance in Butaleja district Uganda:
Makerere University; 2006.
53. Tan H-F, Yeh C-Y, Chang H-W, Chang C-K, Tseng H-F. Private doctors’
practices, knowledge, and attitude to reporting of communicable diseases:
a national survey in Taiwan. BMC Infect Dis. 2009;9(11).
54. Barakat A, Ihazmad H, Benkaroum S, et al. Influenza surveillance among
outpatients and inpatients in Morocco, 1996-2009. PLoS One. 2011;6(9):
e24579.
55. Arora VK, Lonnroth K, Sarin R. Improved case detection of tuberculosis through
a public-private partnership. Indian J Chest Dis Allied Sci. 2003;46(2):133–6.
56. Portero JL, Rubio M. Private practitioners and tuberculosis control in the
Philippines: strangers when they meet? Trop Med Int Health. 2003;8(4):329–35.
57. Chengsorn N, Bloss E, Anekvorapong R, et al. Tuberculosis services and
treatment outcomes in private and public health care facilities in Thailand,
2004-2006. Int J Tuberc Lung Dis. 2009;13(7):888–94.
58. Chughtai AA, Qadeer E, Khan W, Hadi H, Memon IA. Estimation of the
contribution of private providers in tuberculosis case notification and
treatment outcome in Pakistan. East Med Health J. 2013;19(3):213–8.
59. Newell JN, Pande SB, Baral SC, Bam DS, Malla P. Control of tuberculosis in
an urban setting in Nepal: public-private partnership. Bull World Health
Organ. 2004;82(2):92–8.
60. Yimer SA, Holm-Hansen C, Bjune G. Assessment of knowledge and practice
of private practitioners regarding tuberculosis control in Ethiopia. Journal of
infection in developing countries. 2012;6(1):13–9.61. Phalkey RK, Yamamoto S, Awate P, Marx M. Challenges with the
implementation of an integrated disease surveillance and response (IDSR)
system: systematic review of the lessons learned. Health Policy Plan. 2013.
62. Kirsch TD, Harvey M. A role for the private sector in poliomyelitis
surveillance? World Health Forum. 1994;15:240–3.
63. Smith E, Brugha R, Zwi a. Working with private sector providers for better
health care: an introductory guide. London Options Consultancy; 2001.
Available at http://www.who.int/management/partnerships/private/
privatesectorguide.pdf. Accessed 25 Apr 2016.
64. Chitkara AJ, Thacker N, Vashishtha VM, Bansal CP, Gupta SG. Adverse event
following immunization (AEFI) surveillance in India: position paper of Indian
academy of pediatrics, 2013. Indian Pediatr. 2013;50(8):739–41.
65. WHO. Best practices in engagement of all health-care providers in the
management of drug-resistant tuberculosis. Geneva; 2015.
66. Nagaraja SB, Achanta S, Kumar AM, Satyanarayana S. Extending
tuberculosis notification to the private sector in India: programmatic
challenges? Int J Tuberc Lung Dis. 2014;18(11):1353–6.
67. Gelberg KH, Brissette IF, Cummings K. Evaluation of a communications
campaign to increase physician reporting to a surveillance system. Public
Health Rep. 2011;126(1):19–27.
68. Smith G. Develoment of rapid eidemiologic assessment methods to evaluate
health status and delivery of health services. Int J Epidemiol. 1989;18(4):S2–S15.
69. Gueye D, Banke KK, Mmbuji P. Follow- up monitoring and evaluation of
integrated disease surveillance and response in Tanzania. Bethesda: The
Partners for health Reformplus Project Abt Associates Inc.; 2006. Available at
http://phrplus.org/Pubs/Tech094_fin.pdf.
70. Quality Health Partners (QHP) and GHS. 2005. Facility Baseline Assessment
of Regional Hospitals and Facilities in 28 Target Districts in Seven Regions of
Ghana. Accra.
71. Sathyanarayana. An evaluation of Integrated Disease Surveillance Project
(IDSP); Bellary Unit, Karnataka, India. In: District Surveillance Unit I, editor.
Bellary: Ministry of Health and Family Welfare, Karnataka state; NA.
72. Kumar MKA, Dewan PK, Nair PKJ, et al. Improved tuberculosis case detection
through public-private partnership and laboratory-based surveillance, Kannur
District, Kerala, India, 2001-2002. Int J Tuberc Lung Dis. 2005;9(8):870–6.
73. Lönnroth K, Karlsson M, Lan NTN, Buu TN, Dieu TTN. Referrig TB suspects
from private phamacies to the National Tuberculosis Programme:
experiences from two districts in ho chi Minh City, Vietnam. Int J Tuberc
Lung Dis. 2003;7(12):1147–53.
74. Vu DH, Van Rein N, Cobelens FGJ, Nguyen TTH, Le VH, Brouwers JRBJ.
Suspected tuberculosis case detection and referral in private pharmacies in
Viet Nam. Int J Tuberc Lung Dis. 2012;16(12):1625–9.
75. Brissette I, Gelberg KH, Grey AJ. The effect of message type on physician
compliance with disease reporting requirements. Public Health Rep. 2006;
121(6):703–9.
76. de Villiers PJ, Geffen LN. The development of passive health surveillance by
a sentinel network of family practitioners in South Africa. S Afr Med J. 1998;
88(3):256–9.
77. Lei X, Liu Q, Escobar E, et al. Public-private mix for tuberculosis care and
control: a systematic review. Int J Infect Dis. 2015;34:20–32.
78. Kumar MK, Dewan PK, Nair PK, et al. Improved tuberculosis case detection
through public-private partnership and laboratory-based surveillance, Kannur
District, Kerala, India, 2001-2002. Int J Tuberc Lung Dis. 2005;9(8):870–6.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
